{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:53:03Z","timestamp":1790473983874,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001797","name":"Curtin University of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001797","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12944-016-0330-4","type":"journal-article","created":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T08:38:39Z","timestamp":1475138319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Plasma triglyceride and high density lipoprotein cholesterol are poor surrogate markers of pro-atherogenic chylomicron remnant homeostasis in subjects with the metabolic syndrome"],"prefix":"10.1186","volume":"15","author":[{"given":"Deasy","family":"Irawati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C. L.","family":"Mamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satvinder S.","family":"Dhaliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario J.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin M.","family":"Slivkoff-Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,29]]},"reference":[{"issue":"5","key":"330_CR1","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1161\/CIRCULATIONAHA.104.516948","volume":"112","author":"JM Dekker","year":"2005","unstructured":"Dekker JM, et al. Metabolic syndrome and 10-year cardiovascular disease risk in the hoorn study. Circulation. 2005;112(5):666\u201373.","journal-title":"Circulation"},{"issue":"10","key":"330_CR2","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.amjmed.2006.02.031","volume":"119","author":"A Galassi","year":"2006","unstructured":"Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006;119(10):812\u20139.","journal-title":"Am J Med"},{"key":"330_CR3","first-page":"857","volume-title":"The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns","author":"J Wang","year":"2007","unstructured":"Wang J, et al. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns, vol. 28. 2007. p. 857\u201364."},{"key":"330_CR4","first-page":"784536","volume":"2012","author":"GH Tomkin","year":"2012","unstructured":"Tomkin GH, Owens D. The chylomicron: relationship to atherosclerosis. Int J Vasc Med. 2012;2012:784536.","journal-title":"Int J Vasc Med"},{"issue":"3","key":"330_CR5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.CIR.60.3.473","volume":"60","author":"DBPD Zilversmit","year":"1979","unstructured":"Zilversmit DBPD. Atherogenesis: a postprandial phenomenon. Circulation. 1979;60(3):473\u201385.","journal-title":"Circulation"},{"issue":"7","key":"330_CR6","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-2362.2011.02635.x","volume":"42","author":"A Alipour","year":"2012","unstructured":"Alipour A, et al. Exploring the value of apoB48 as a marker for atherosclerosis in clinical practice. Eur J Clin Investig. 2012;42(7):702\u20138.","journal-title":"Eur J Clin Investig"},{"issue":"9","key":"330_CR7","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1365-2362.2012.02687.x","volume":"42","author":"D Masuda","year":"2012","unstructured":"Masuda D, et al. Correlation of fasting serum apolipoprotein B-48 with coronary artery disease prevalence. Eur J Clin Investig. 2012;42(9):992\u20139.","journal-title":"Eur J Clin Investig"},{"issue":"1\u20132","key":"330_CR8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cca.2007.12.012","volume":"390","author":"T Nakano","year":"2008","unstructured":"Nakano T, et al. Detection of apolipoproteins B-48 and B-100 carrying particles in lipoprotein fractions extracted from human aortic atherosclerotic plaques in sudden cardiac death cases. Clin Chim Acta. 2008;390(1\u20132):38\u201343.","journal-title":"Clin Chim Acta"},{"issue":"6","key":"330_CR9","first-page":"792","volume":"41","author":"S Pal","year":"2003","unstructured":"Pal S, et al. Identification of lipoproteins of intestinal origin in human atherosclerotic plaque. Clin Chem Lab Med. 2003;41(6):792\u20135.","journal-title":"Clin Chem Lab Med"},{"issue":"9","key":"330_CR10","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.0000084638.14534.0A","volume":"23","author":"SD Proctor","year":"2003","unstructured":"Proctor SD, Mamo JC. Intimal retention of cholesterol derived from apolipoprotein b100- and apolipoprotein b48-containing lipoproteins in carotid arteries of watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol. 2003;23(9):1595.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"330_CR11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.atherosclerosis.2015.09.018","volume":"243","author":"D Irawati","year":"2015","unstructured":"Irawati D, et al. Hypertriglyceridemic subjects exhibit an accumulation of small dense chylomicron particles in the fasting state. Atherosclerosis. 2015;243(1):236\u201341.","journal-title":"Atherosclerosis"},{"issue":"4","key":"330_CR12","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/MOL.0b013e328355ee5e","volume":"23","author":"F Karpe","year":"2012","unstructured":"Karpe F. Chylomicron production as a feature of atherogenic lipoproteins. Curr Opin Lipidol. 2012;23(4):398\u20139.","journal-title":"Curr Opin Lipidol"},{"issue":"2","key":"330_CR13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.atherosclerosis.2004.12.045","volume":"181","author":"H Campos","year":"2005","unstructured":"Campos H, Khoo C, Sacks FM. Diurnal and acute patterns of postprandial apolipoprotein B-48 in VLDL, IDL, and LDL from normolipidemic humans. Atherosclerosis. 2005;181(2):345\u201351.","journal-title":"Atherosclerosis"},{"issue":"1\u20132","key":"330_CR14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0021-9150(94)93515-7","volume":"109","author":"JCL Mamo","year":"1994","unstructured":"Mamo JCL, Wheeler JR. Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as smaller macromolecules including LDL, HDL and albumin. Atherosclerosis. 1994;109(1\u20132):126.","journal-title":"Atherosclerosis"},{"issue":"3","key":"330_CR15","first-page":"239","volume":"7","author":"SD Proctor","year":"1996","unstructured":"Proctor SD, Mamo JCL. Arterial fatty lesions have increased uptake of chylomicron remnants but not low-density lipoproteins. Coron Artery Dis. 1996;7(3):239\u201345.","journal-title":"Coron Artery Dis"},{"key":"330_CR16","doi-asserted-by":"crossref","unstructured":"Yu KCW, Mamo JCL. Chylomicron-remnant-induced foam cell formation and cytotoxicity: A possible mechanism of cell death in atherosclerosis. Clinical Science, 2000;98(2):183\u201392.","DOI":"10.1042\/cs0980183"},{"key":"330_CR17","doi-asserted-by":"crossref","unstructured":"Batt KV, et al. Differential effects of low-density lipoprotein and chylomicron remnants on lipid accumulation in human macrophages. Experimental Biology and Medicine, 2004;229(6):528\u201337.","DOI":"10.1177\/153537020422900611"},{"issue":"4","key":"330_CR18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.5551\/jat.No604","volume":"16","author":"M Kinoshita","year":"2009","unstructured":"Kinoshita M, et al. Increased serum apolipoprotein B48 concentration in patients with metabolic syndrome. J Atheroscler Thromb. 2009;16(4):517\u201322.","journal-title":"J Atheroscler Thromb"},{"issue":"1\u20132","key":"330_CR19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cca.2011.09.013","volume":"413","author":"H Hanada","year":"2012","unstructured":"Hanada H, et al. Establishment of chemiluminescence enzyme immunoassay for apolipoprotein B-48 and its clinical applications for evaluation of impaired chylomicron remnant metabolism. Clin Chim Acta. 2012;413(1\u20132):160\u20135.","journal-title":"Clin Chim Acta"},{"issue":"6","key":"330_CR20","doi-asserted-by":"crossref","first-page":"618","DOI":"10.5551\/jat.22558","volume":"21","author":"D Masuda","year":"2014","unstructured":"Masuda D, et al. Reference interval for the apolipoprotein B-48 concentration in healthy Japanese individuals. J Atheroscler Thromb. 2014;21(6):618\u201327.","journal-title":"J Atheroscler Thromb"},{"issue":"6","key":"330_CR21","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1194\/jlr.M300090-JLR200","volume":"44","author":"N Sakai","year":"2003","unstructured":"Sakai N, et al. Measurement of fasting serum apoB-48 levels in normolipidemic and hyperlipidemic subjects by ELISA. J Lipid Res. 2003;44(6):1256\u201362.","journal-title":"J Lipid Res"},{"issue":"1","key":"330_CR22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5551\/jat.E596","volume":"16","author":"I Sato","year":"2009","unstructured":"Sato I, et al. Significance of measuring serum concentrations of remnant lipoproteins and apolipoprotein B-48 in fasting period. J Atheroscler Thromb. 2009;16(1):12\u201320.","journal-title":"J Atheroscler Thromb"},{"issue":"6","key":"330_CR23","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1161\/01.ATV.0000222015.76038.14","volume":"26","author":"H Duez","year":"2006","unstructured":"Duez H, et al. Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans. Arterioscler Thromb Vasc Biol. 2006;26(6):1357\u201363.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"330_CR24","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.numecd.2007.12.003","volume":"18","author":"G Annuzzi","year":"2008","unstructured":"Annuzzi G, et al. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance. Nutr Metab Cardiovasc Dis. 2008;18(8):531\u20138.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"330_CR25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0021-9150(96)05832-7","volume":"124","author":"E Meyer","year":"1996","unstructured":"Meyer E, et al. Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70\u00a0% stenotic coronary artery disease: a case-control study. Atherosclerosis. 1996;124(2):221\u201335.","journal-title":"Atherosclerosis"},{"key":"330_CR26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2362.1998.00284.x","volume":"28","author":"J Mamo","year":"1998","unstructured":"Mamo J, et al. Accumulation of chylomicron remnants in homozygous subjects with familial hypercholesterolaemia. Eur J Clin Invest. 1998;28:379\u201384.","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"330_CR27","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00394-015-0968-0","volume":"55","author":"V Lam","year":"2016","unstructured":"Lam V, et al. Serum 25-hydroxyvitamin D is associated with reduced verbal episodic memory in healthy, middle-aged and older adults. Eur J Nutr. 2016;55(4):1503\u201313.","journal-title":"Eur J Nutr"},{"issue":"16","key":"330_CR28","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KGMM Alberti","year":"2009","unstructured":"Alberti KGMM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; And international association for the study of obesity. Circulation. 2009;120(16):1640\u20135.","journal-title":"Circulation"},{"key":"330_CR29","volume-title":"Anthropometrica","author":"K Norton","year":"2000","unstructured":"Norton K, Olds T. Anthropometrica. Sydney: University of New South Wales Press; 2000."},{"issue":"7","key":"330_CR30","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0009-9120(00)00162-4","volume":"33","author":"E Bairaktari","year":"2000","unstructured":"Bairaktari E, et al. Estimation of LDL cholesterol based on the friedewald formula and on apo B levels. Clin Biochem. 2000;33(7):549\u201355.","journal-title":"Clin Biochem"},{"issue":"1","key":"330_CR31","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1152\/ajpendo.00645.2007","volume":"294","author":"R Muniyappa","year":"2008","unstructured":"Muniyappa R, et al. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008;294(1):E15\u201326.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"330_CR32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0005-2760(96)00041-0","volume":"1300","author":"MM Hussain","year":"1996","unstructured":"Hussain MM, et al. Chylomicron assembly and catabolism: role of apolipoproteins and receptors. Biochim Biophys Acta. 1996;1300(3):151\u201370.","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"330_CR33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cccn.2004.08.008","volume":"351","author":"M Kinoshita","year":"2005","unstructured":"Kinoshita M, et al. Determination of apolipoprotein B-48 in serum by a sandwich ELISA. Clin Chim Acta. 2005;351(1\u20132):115\u201320.","journal-title":"Clin Chim Acta"},{"key":"330_CR34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1567-5688(15)50004-4","volume":"17","author":"M Arca","year":"2015","unstructured":"Arca M. Alterations of intestinal lipoprotein metabolism in diabetes mellitus and metabolic syndrome. Atheroscler Suppl. 2015;17:12\u20136.","journal-title":"Atheroscler Suppl"},{"issue":"1","key":"330_CR35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/14791130410001728524","volume":"2","author":"DC Chan","year":"2004","unstructured":"Chan DC, Watts GF. Dyslipidemia in the metabolic syndrome. J Drug Eval. 2004;2(1):3\u201334.","journal-title":"J Drug Eval"},{"issue":"13\u201314","key":"330_CR36","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.clinbiochem.2009.05.018","volume":"42","author":"R Meshkani","year":"2009","unstructured":"Meshkani R, Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem. 2009;42(13\u201314):1331\u201346.","journal-title":"Clin Biochem"},{"issue":"3","key":"330_CR37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/CS20040109","volume":"107","author":"DC Chan","year":"2004","unstructured":"Chan DC, Barrett PHR, Watts GF. Lipoprotein transport in the metabolic syndrome: Pathophysiological and interventional studies employing stable isotopy and modelling methods. Clin Sci. 2004;107(3):233\u201349.","journal-title":"Clin Sci"},{"issue":"6","key":"330_CR38","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1172\/JCI115535","volume":"88","author":"CJ Mann","year":"1991","unstructured":"Mann CJ, et al. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Investig. 1991;88(6):2059\u201366.","journal-title":"J Clin Investig"},{"issue":"8","key":"330_CR39","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1194\/jlr.R027011","volume":"53","author":"MA Charles","year":"2012","unstructured":"Charles MA, Kane JP. New molecular insights into CETP structure and function: a review. J Lipid Res. 2012;53(8):1451\u20138.","journal-title":"J Lipid Res"},{"issue":"6","key":"330_CR40","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0009-9120(03)00078-X","volume":"36","author":"S Rashid","year":"2003","unstructured":"Rashid S, et al. Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: The combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity. Clin Biochem. 2003;36(6):421\u20139.","journal-title":"Clin Biochem"},{"issue":"3","key":"330_CR41","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/MOL.0b013e328338cabc","volume":"21","author":"KJ Williams","year":"2010","unstructured":"Williams KJ, Chen K. Recent insights into factors affecting remnant lipoprotein uptake. Curr Opin Lipidol. 2010;21(3):218\u201328.","journal-title":"Curr Opin Lipidol"},{"key":"330_CR42","doi-asserted-by":"crossref","first-page":"S1175","DOI":"10.1161\/CIRCULATIONAHA.107.751412","volume":"120","author":"K Chen","year":"2009","unstructured":"Chen K, et al. Metabolic factors in type 2 diabetes augment hepatocyte expression of SULF2, a novel suppressor of remnant lipoprotein uptake. Circulation. 2009;120:S1175.","journal-title":"Circulation"},{"key":"330_CR43","doi-asserted-by":"publisher","unstructured":"Ferri N, Ruscica M. Proprotein convertase subtilisin\/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia. Endocrine. 2016. doi: 10.1007\/s12020-016-0939-0 .","DOI":"10.1007\/s12020-016-0939-0"},{"issue":"4","key":"330_CR44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jacl.2008.06.013","volume":"2","author":"MJ Blaha","year":"2008","unstructured":"Blaha MJ, et al. The importance of non\u2013HDL cholesterol reporting in lipid management. J Clin Lipidol. 2008;2(4):267\u201373.","journal-title":"J Clin Lipidol"},{"issue":"5","key":"330_CR45","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2337\/db04-1084","volume":"55","author":"LM Federico","year":"2006","unstructured":"Federico LM, et al. Intestinal insulin resistance and aberrant production of apolipoprotein B48 lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia: Evidence for activation of protein tyrosine phosphatase-1B, extracellular signal-related kinase, and sterol regulatory element-binding protein-1c in the fructose-fed hamster intestine. Diabetes. 2006;55(5):1316\u201326.","journal-title":"Diabetes"},{"issue":"35","key":"330_CR46","doi-asserted-by":"crossref","first-page":"31646","DOI":"10.1074\/jbc.M200544200","volume":"277","author":"M Haidari","year":"2002","unstructured":"Haidari M, et al. Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance: evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction. J Biol Chem. 2002;277(35):31646\u201355.","journal-title":"J Biol Chem"},{"issue":"5","key":"330_CR47","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1172\/JCI116821","volume":"92","author":"SK Fried","year":"1993","unstructured":"Fried SK, et al. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Investig. 1993;92(5):2191\u20138.","journal-title":"J Clin Investig"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-016-0330-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T23:27:09Z","timestamp":1568417229000},"score":1,"resource":{"primary":{"URL":"http:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-016-0330-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,29]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["330"],"URL":"https:\/\/doi.org\/10.1186\/s12944-016-0330-4","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,29]]},"article-number":"169"}}